Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 3Phase 2 2

Status

Unknown 17Recruiting 6Withdrawn 3Terminated 3Active not recruiting 3Not yet recruiting 2Completed 2

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Multiple Myeloma 2Leukemia, Myeloid, Acute 1Colorectal Neoplasms 1

Interventions

pembrolizumab 75Carboplatin 61Cyclophosphamide 58Nivolumab 50Paclitaxel 47Gemcitabine 44Cisplatin 43Dexamethasone 41Radiotherapy 35Rituximab 32Capecitabine 31Docetaxel 29Bevacizumab 29fludarabine 27atezolizumab 26Cytarabine 26avelumab 24Trastuzumab 23Oxaliplatin 23Lenalidomide 23Cetuximab 23venetoclax 22Fluorouracil 22Azacitidine 22Temozolomide 21Ipilimumab 21130-nm albumin-bound paclitaxel 21fludarabine phosphate 20Filgrastim 20Bortezomib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × Immunotherapy, Adoptive × Clear all
NCT04097301 2022-01-19

Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma

AGC Biologics S.p.A.

Phase 1/2 Terminated
8 enrolled 13 charts
Other hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Myeloid, Acute

NCT01239368 2019-12-10

Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
34 enrolled 17 charts
Plasma cell

Multiple Myeloma

NCT03431311 2019-06-13

TCR-CRC-001

Oslo University Hospital

Phase 1/2 Terminated
1 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡